Hemp News Today — October 22, 2026
Nebraska cannabis growers face up to 2-year wait to sell products and more — today's hemp signal.
The hemp and cannabis industry continues to navigate complex regulatory landscapes and logistical challenges. In Nebraska, cannabis growers are facing significant delays, with waits of up to two years to sell their products, highlighting the hurdles that businesses face in bringing their goods to market. Meanwhile, companies like Vireo are expanding their presence in key markets, such as Florida, where they have made a $21 million purchase to deepen their foothold.
The industry is also grappling with the aftermath of the 2018 Farm Bill and its impact on hemp-derived products like CBD. A Trump-era CBD reimbursement program has stalled, and there are concerns about an impending federal hemp ban. Amidst these uncertainties, companies are working to ensure the quality and compliance of their products. For example, Flower Infusion recently released lab results showing that their FX-8 product meets strict standards. However, not all companies are avoiding controversy, with Curaleaf facing questions about its business dealings and potential liabilities in Michigan. These developments underscore the complexities and challenges facing the hemp and cannabis industry as it continues to evolve.
Today's signal:
• Nebraska cannabis growers face up to 2-year wait to sell products (mjbizdaily.com)
• Cannabis MSO Vireo deepens Florida foothold with latest $21 million purchase (mjbizdaily.com)
• Trump CBD reimbursement program stalls ahead of federal hemp ban (mjbizdaily.com)
• Flower Infusion Lab Results: Independent Test Finds the FX-8 Within ±5% Across the Drum (mjbizdaily.com)
• Did Curaleaf put all cannabis contracts at risk to avoid paying millions to a Michigan cultivator? (mjbizdaily.com)